TNP-470 suppresses the tumorigenicity of HT1080 fibrosarcoma tumor through the inhibition of VEGF secretion from the tumor cells

Sarcoma

Volumn 5, Issue 4, 2001, Pages 197-202

  Kaya, Mitsunori ^a   Wada, Takuro ^a   Nagoya, Satoshi ^a   Kawaguchi, Satoshi ^a   Yamashita, Toshihiko ^a   Yamamoto, Nobuyuki ^a   Yoshimoto, Mitsunori ^a   Okada, Futoshi ^b   Ishii, Seiichi ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; FUMAGILLOL CHLOROACETYLCARBAMATE; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENICITY; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFECT; ENDOTHELIUM CELL; FEMALE; FIBROSARCOMA; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SARCOMA CELL; TUMOR CELL;

EID: 0035700049     PISSN: 1357714X     EISSN: None     Source Type: Journal    
DOI: 10.1080/13577140120099182     Document Type: Article

References (32)

1. Pulmonary metastases from soft tissue sarcoma: Analysis of patterns of diseases and postmetastasis survival
2. Concentration of vascular endothelial growth factor in the tumour tissue as a prognostic factor of soft tissue sarcomas
3. Vascular endothelial growth factor and soft tissue sarcomas: Tumor expression correlates with grade
4. Tumor angiogenesis: Therapeutic implications
5. Anti-angiogenesis: New concept for therapy of solid tumors
6. What is the evidence that tumors are angiogenesis dependent?
7. Angiogenesis in cancer, vascular, rheumatoid and other disease
8. Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma
9. Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases
10. Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth
11. Potent anti-angiogenic action of AGM-1470: Comparison to the fumagillin parent
12. A phase I and pharmacokinetic study of TNP-470 administered weekly to patients with advanced cancer
13. A phase I study of TNP-470 administered to patients with advanced squamous cell cancer of the cervix
14. J multi-institutional study of the angiogenesis inhibitor TNP-470 in metastatic renal carcinoma
15. Efficacy of the angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (AGM-1470) on osteosarcoma growth and lung metastasis in rats
16. Suppression of pulmonary metastasis by angiogenesis inhibitor TNP-470 in murine osteosarcoma
17. Spontaneous transformation and immortalization of human endothelial cells
18. Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenesis
19. Inhibition of angiogenesis induces chromaffin differentiation and apoptosis in neuroblastoma
20. Characterization of a taxol-resistant human small-cell lung cancer cell line
21. Removal of beta III isotype enhances taxol induced microtubule assembly
22. AGM-1470, a potent angiogenesis inhibitor, prevents the entry of normal but not transformed endothelial cells into the G1 phase of the cell cycle
23. Cystostatic inhibition of endothelial cell growth by the angiogenesis inhibitor TNP-470 (AGM-1470)
24. In vitro inhibition of endothelial cell growth by the antiangiogenic drug AGM-1470 (TNP-470) and the antiendoglin antibody TEC-11
25. Inhibition of liver metastasis of human pancreatic carcinoma by angiogenesis inhibitor TNP-470 in combination with cisplatin
26. TNP-470 inhibits growth and the production of vascular endothelial growth factor of uterine carcinosarcoma cells in vitro
27. Suppression of tumor growth and downregulation of platelet-derived endothelial cellgrowth factor/thymidine phosphorylase in tumor cells by angiogenesis inhibitor TNP-470
28. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived follicles stellate cells
29. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for endothelial cells
30. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor
31. Nucleotide sequence and expression of a novel human receptor type tyrosine kinase gene (flk) closely related to the fms family
32. Vascular endothelial growth factor (VEGF) expression in untreated osteosarcoma is predictive of pulmonary metastasis and poor prognosis